tiprankstipranks
Trending News
More News >
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
Advertisement

Medicenna Therapeutics Corp (MDNAF) Income Statement

Compare
221 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q4 2024), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Medicenna Therapeutics Corp's net income was C$1.19M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -55.00KC$ -5.00KC$ -5.00KC$ -38.00KC$ -40.00K
Operating Expenses
C$ 21.58MC$ 19.66MC$ 16.30MC$ 22.47MC$ 17.39M
Depreciation and Amortization
C$ 55.00KC$ 5.00KC$ 5.00KC$ 38.00KC$ 40.00K
EBITDA
C$ -12.97MC$ -18.67MC$ -16.30MC$ -22.54MC$ -17.25M
Operating Income
C$ -21.63MC$ -19.66MC$ -21.64MC$ -22.30MC$ -17.19M
Other Income/Expenses
C$ 8.60MC$ -5.80MC$ 7.00MC$ 1.65MC$ 106.00K
Pretax Income
C$ -13.03MC$ -25.47MC$ -10.05MC$ -22.58MC$ -17.29M
Net Income
C$ -11.80MC$ -25.47MC$ 1.55MC$ -22.65MC$ -17.18M
Per Share Metrics
Basic EPS
C$ -0.15C$ -0.37C$ 0.02C$ -0.42C$ -0.35
Diluted EPS
C$ -0.15C$ -0.37C$ 0.02C$ -0.42C$ -0.35
Weighted Average Shares Outstanding
76.67M 69.64M 64.74M 54.29M 49.66M
Weighted Average Shares Outstanding (Diluted)
76.67M 69.64M 64.74M 54.29M 49.66M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis